Isabel Peña-Rømer

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Replacement Therapy

Tyrosine Kinase

Quality Control

Top Venues

The EMBO journal

This page only lists publications with an associated author ORCID identifier.

Publications

Jan-Erik Messling, Isabel Peña-Rømer, Ann Sophie Moroni, Sarah Bruestl, Kristian Helin
RIO-kinase 2 is essential for hematopoiesis. PloS one 19 (4) (2024)
Jan-Erik Messling, Isabel Peña-Rømer, Ann Sophie Moroni, Sarah Bruestl, Kristian Helin
RIO-kinase 2 is essential for hematopoiesis. PloS one 19 (4) (2024)
Jan-Erik Messling, Isabel Peña-Rømer, Ann Sophie Moroni, Sarah Bruestl, Kristian Helin
RIO-kinase 2 is essential for hematopoiesis. PloS one 19 (4) (2024)
Jan-Erik Messling, Isabel Peña-Rømer, Ann Sophie Moroni, Sarah Bruestl, Kristian Helin
RIO-kinase 2 is essential for hematopoiesis. PloS one 19 (4) (2024)
Aliaksandra Radzisheuskaya, Isabel Peña-Rømer, Eugenia Lorenzini, Richard Koche, Yingqian Zhan, Pavel V Shliaha, Alexandra J Cooper, Zheng Fan, Daria Shlyueva, Jens V Johansen, Ronald C Hendrickson, Kristian Helin
An alternative NURF complex sustains acute myeloid leukemia by regulating the accessibility of insulator regions. The EMBO journal (2023)